| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 46 | 2024 | 808 | 7.350 |
Why?
|
| Tomography, X-Ray Computed | 147 | 2023 | 20130 | 5.000 |
Why?
|
| Lung | 126 | 2023 | 9857 | 4.820 |
Why?
|
| Radiography, Thoracic | 28 | 2022 | 1265 | 4.400 |
Why?
|
| Lung Diseases | 35 | 2023 | 1887 | 4.290 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 15 | 2023 | 451 | 3.240 |
Why?
|
| Bronchiectasis | 6 | 2023 | 128 | 2.800 |
Why?
|
| Magnetic Resonance Imaging | 107 | 2021 | 35425 | 2.540 |
Why?
|
| Pulmonary Embolism | 31 | 2023 | 2375 | 2.450 |
Why?
|
| Pulmonary Emphysema | 19 | 2022 | 672 | 2.150 |
Why?
|
| Lung Neoplasms | 67 | 2023 | 13104 | 2.090 |
Why?
|
| Pulmonary Fibrosis | 9 | 2023 | 530 | 1.930 |
Why?
|
| Image Enhancement | 33 | 2021 | 2921 | 1.870 |
Why?
|
| Emphysema | 7 | 2022 | 247 | 1.670 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 23 | 2023 | 3047 | 1.640 |
Why?
|
| Optic Flow | 2 | 2022 | 14 | 1.630 |
Why?
|
| Respiratory Function Tests | 26 | 2021 | 1617 | 1.540 |
Why?
|
| Pulmonary Circulation | 22 | 2007 | 739 | 1.500 |
Why?
|
| Exhalation | 11 | 2019 | 167 | 1.500 |
Why?
|
| Solitary Pulmonary Nodule | 10 | 2018 | 266 | 1.460 |
Why?
|
| Pleural Neoplasms | 7 | 2016 | 607 | 1.380 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 12 | 2016 | 1184 | 1.330 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 30 | 2023 | 5223 | 1.270 |
Why?
|
| Pulmonary Artery | 23 | 2023 | 1912 | 1.190 |
Why?
|
| Mucormycosis | 2 | 2018 | 97 | 1.180 |
Why?
|
| Radiographic Image Enhancement | 10 | 2014 | 885 | 1.140 |
Why?
|
| Pleura | 3 | 2017 | 235 | 1.100 |
Why?
|
| Asbestos | 2 | 2017 | 251 | 1.050 |
Why?
|
| Image Processing, Computer-Assisted | 31 | 2019 | 8949 | 1.040 |
Why?
|
| Helium | 6 | 2014 | 123 | 1.000 |
Why?
|
| Pleural Diseases | 3 | 2017 | 139 | 0.990 |
Why?
|
| Pulmonary Ventilation | 9 | 2009 | 374 | 0.980 |
Why?
|
| Mesothelioma | 5 | 2012 | 818 | 0.970 |
Why?
|
| Radiation Dosage | 9 | 2016 | 1928 | 0.930 |
Why?
|
| Contrast Media | 43 | 2021 | 5300 | 0.920 |
Why?
|
| Diaphragm | 8 | 2021 | 349 | 0.910 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 2021 | 61 | 0.900 |
Why?
|
| Humans | 367 | 2024 | 744366 | 0.900 |
Why?
|
| Image Interpretation, Computer-Assisted | 12 | 2021 | 3326 | 0.870 |
Why?
|
| Mucin-5B | 9 | 2023 | 141 | 0.860 |
Why?
|
| Pneumonia | 12 | 2020 | 2133 | 0.850 |
Why?
|
| Respiration | 21 | 2019 | 1653 | 0.840 |
Why?
|
| Radiation Protection | 4 | 2016 | 419 | 0.810 |
Why?
|
| Angiography | 10 | 2010 | 1639 | 0.810 |
Why?
|
| X-Rays | 5 | 2022 | 301 | 0.800 |
Why?
|
| Radiography | 14 | 2024 | 7023 | 0.780 |
Why?
|
| Symbiosis | 1 | 2024 | 287 | 0.780 |
Why?
|
| Gadolinium DTPA | 14 | 2012 | 836 | 0.760 |
Why?
|
| Imaging, Three-Dimensional | 14 | 2010 | 4042 | 0.750 |
Why?
|
| Xenon Isotopes | 5 | 2014 | 65 | 0.730 |
Why?
|
| Thoracic Diseases | 4 | 2017 | 97 | 0.730 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 264 | 0.730 |
Why?
|
| Magnetic Resonance Angiography | 13 | 2004 | 1443 | 0.710 |
Why?
|
| Aged | 157 | 2022 | 163288 | 0.710 |
Why?
|
| Incidental Findings | 3 | 2020 | 689 | 0.710 |
Why?
|
| Aged, 80 and over | 79 | 2021 | 57776 | 0.710 |
Why?
|
| Ventilation-Perfusion Ratio | 9 | 2007 | 116 | 0.690 |
Why?
|
| Smoking | 19 | 2024 | 8987 | 0.680 |
Why?
|
| Pulmonary Edema | 1 | 2022 | 414 | 0.670 |
Why?
|
| Forced Expiratory Volume | 12 | 2022 | 1745 | 0.650 |
Why?
|
| Oxygen | 16 | 2023 | 4189 | 0.650 |
Why?
|
| Middle Aged | 171 | 2023 | 213390 | 0.640 |
Why?
|
| Thymus Gland | 3 | 2015 | 1267 | 0.640 |
Why?
|
| Body Burden | 2 | 2009 | 158 | 0.630 |
Why?
|
| Lung Diseases, Fungal | 2 | 2019 | 122 | 0.630 |
Why?
|
| Patient Care | 1 | 2024 | 640 | 0.620 |
Why?
|
| Artifacts | 11 | 2009 | 1904 | 0.620 |
Why?
|
| Respiratory Mechanics | 6 | 2011 | 686 | 0.610 |
Why?
|
| Patient Care Management | 1 | 2021 | 306 | 0.600 |
Why?
|
| Female | 215 | 2023 | 380193 | 0.580 |
Why?
|
| Respiratory System Abnormalities | 3 | 2022 | 69 | 0.580 |
Why?
|
| Male | 202 | 2023 | 350115 | 0.580 |
Why?
|
| Tomography, Spiral Computed | 4 | 2008 | 280 | 0.580 |
Why?
|
| Virus Diseases | 1 | 2023 | 711 | 0.570 |
Why?
|
| Tumor Burden | 13 | 2023 | 1915 | 0.570 |
Why?
|
| Arthritis, Rheumatoid | 9 | 2024 | 3712 | 0.550 |
Why?
|
| Sarcoidosis, Pulmonary | 3 | 2018 | 43 | 0.540 |
Why?
|
| Sensitivity and Specificity | 38 | 2018 | 14723 | 0.540 |
Why?
|
| Observer Variation | 10 | 2019 | 2593 | 0.520 |
Why?
|
| Radiology | 6 | 2020 | 2099 | 0.510 |
Why?
|
| Herpes Simplex | 1 | 2018 | 470 | 0.510 |
Why?
|
| Adult | 141 | 2022 | 214052 | 0.510 |
Why?
|
| Thymus Neoplasms | 4 | 2018 | 268 | 0.500 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2006 | 168 | 0.500 |
Why?
|
| Protein Kinase Inhibitors | 14 | 2021 | 5534 | 0.460 |
Why?
|
| Diagnostic Imaging | 9 | 2018 | 3508 | 0.450 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 2725 | 0.450 |
Why?
|
| Artificial Intelligence | 3 | 2022 | 2213 | 0.450 |
Why?
|
| Xenon | 2 | 2012 | 110 | 0.450 |
Why?
|
| Thorax | 5 | 2019 | 547 | 0.440 |
Why?
|
| Tidal Volume | 5 | 2019 | 490 | 0.440 |
Why?
|
| Thoracic Neoplasms | 3 | 2021 | 268 | 0.440 |
Why?
|
| Computers, Handheld | 2 | 2004 | 208 | 0.420 |
Why?
|
| Reproducibility of Results | 30 | 2018 | 19905 | 0.410 |
Why?
|
| Movement | 7 | 2019 | 1471 | 0.390 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2010 | 2737 | 0.390 |
Why?
|
| Algorithms | 12 | 2019 | 13882 | 0.380 |
Why?
|
| Retrospective Studies | 46 | 2023 | 77460 | 0.380 |
Why?
|
| Cysts | 1 | 2015 | 678 | 0.360 |
Why?
|
| Early Detection of Cancer | 4 | 2020 | 3086 | 0.360 |
Why?
|
| Neoplasm Staging | 13 | 2021 | 11031 | 0.360 |
Why?
|
| Bronchial Diseases | 3 | 2006 | 151 | 0.360 |
Why?
|
| Health Maintenance Organizations | 1 | 2012 | 642 | 0.340 |
Why?
|
| Tracheal Diseases | 3 | 2005 | 113 | 0.340 |
Why?
|
| Antineoplastic Agents | 12 | 2020 | 13693 | 0.330 |
Why?
|
| Inhalation | 3 | 2013 | 143 | 0.330 |
Why?
|
| Hypertension, Pulmonary | 7 | 2011 | 1534 | 0.330 |
Why?
|
| Traction | 3 | 2023 | 106 | 0.320 |
Why?
|
| Radiometry | 3 | 2014 | 800 | 0.310 |
Why?
|
| Iceland | 4 | 2020 | 183 | 0.310 |
Why?
|
| Molecular Imaging | 2 | 2011 | 828 | 0.290 |
Why?
|
| Quinazolines | 4 | 2016 | 1356 | 0.290 |
Why?
|
| Bronchi | 3 | 2006 | 840 | 0.290 |
Why?
|
| Esophageal Neoplasms | 2 | 2022 | 1585 | 0.280 |
Why?
|
| Forecasting | 2 | 2014 | 2951 | 0.270 |
Why?
|
| Diagnosis, Differential | 15 | 2020 | 12961 | 0.270 |
Why?
|
| Environmental Exposure | 2 | 2018 | 4232 | 0.270 |
Why?
|
| Pneumonectomy | 2 | 2012 | 1094 | 0.270 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 507 | 0.260 |
Why?
|
| Disease Progression | 16 | 2023 | 13286 | 0.260 |
Why?
|
| Peristalsis | 1 | 2005 | 60 | 0.260 |
Why?
|
| Phantoms, Imaging | 7 | 2009 | 2480 | 0.240 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 7658 | 0.240 |
Why?
|
| Pulmonary Alveoli | 4 | 2007 | 675 | 0.240 |
Why?
|
| Thymus Hyperplasia | 2 | 2014 | 30 | 0.240 |
Why?
|
| Bronchial Arteries | 1 | 2004 | 20 | 0.240 |
Why?
|
| Statistical Distributions | 1 | 2004 | 64 | 0.240 |
Why?
|
| Pattern Recognition, Automated | 2 | 2012 | 1005 | 0.240 |
Why?
|
| Pulmonary Veins | 6 | 2009 | 761 | 0.240 |
Why?
|
| Signal Processing, Computer-Assisted | 4 | 2006 | 1534 | 0.230 |
Why?
|
| Incidence | 12 | 2023 | 20952 | 0.230 |
Why?
|
| Equipment Design | 5 | 2020 | 3582 | 0.230 |
Why?
|
| Documentation | 1 | 2009 | 871 | 0.230 |
Why?
|
| Positron-Emission Tomography | 6 | 2018 | 6234 | 0.230 |
Why?
|
| Lymphatic Metastasis | 7 | 2018 | 2924 | 0.220 |
Why?
|
| Prevalence | 9 | 2023 | 15221 | 0.220 |
Why?
|
| Computer Communication Networks | 1 | 2004 | 295 | 0.220 |
Why?
|
| Polymorphism, Genetic | 4 | 2017 | 4328 | 0.210 |
Why?
|
| Posture | 4 | 2017 | 958 | 0.210 |
Why?
|
| Survival Analysis | 4 | 2021 | 10252 | 0.210 |
Why?
|
| Severity of Illness Index | 15 | 2020 | 15535 | 0.210 |
Why?
|
| Isotopes | 4 | 2014 | 124 | 0.200 |
Why?
|
| Sarcoidosis | 2 | 2017 | 506 | 0.200 |
Why?
|
| Fibrosis | 3 | 2023 | 2029 | 0.200 |
Why?
|
| Cohort Studies | 22 | 2022 | 40559 | 0.190 |
Why?
|
| Polyesters | 1 | 2022 | 363 | 0.190 |
Why?
|
| Graves Disease | 8 | 1993 | 242 | 0.190 |
Why?
|
| Bronchography | 4 | 2010 | 74 | 0.190 |
Why?
|
| Noble Gases | 3 | 2007 | 18 | 0.190 |
Why?
|
| Neuroendocrine Tumors | 2 | 2018 | 594 | 0.190 |
Why?
|
| Age Factors | 8 | 2021 | 18373 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 2 | 2020 | 782 | 0.190 |
Why?
|
| Proportional Hazards Models | 8 | 2020 | 12356 | 0.190 |
Why?
|
| Spirometry | 6 | 2021 | 865 | 0.190 |
Why?
|
| Pneumonia, Viral | 1 | 2018 | 3242 | 0.180 |
Why?
|
| Statistics as Topic | 5 | 2011 | 2373 | 0.180 |
Why?
|
| Total Lung Capacity | 4 | 2015 | 143 | 0.180 |
Why?
|
| Hernia, Hiatal | 1 | 2020 | 79 | 0.180 |
Why?
|
| Radiology Information Systems | 1 | 2004 | 523 | 0.170 |
Why?
|
| Feasibility Studies | 8 | 2008 | 5077 | 0.170 |
Why?
|
| Thyroid Gland | 16 | 2019 | 1173 | 0.170 |
Why?
|
| Radiation Pneumonitis | 1 | 2020 | 104 | 0.170 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 1999 | 29 | 0.170 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 2212 | 0.170 |
Why?
|
| Statistics, Nonparametric | 8 | 2013 | 2887 | 0.170 |
Why?
|
| Granuloma | 2 | 2018 | 319 | 0.170 |
Why?
|
| Carcinoma | 2 | 2005 | 2375 | 0.160 |
Why?
|
| Lymphoma | 3 | 2016 | 1877 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 814 | 0.160 |
Why?
|
| Administration, Inhalation | 6 | 2014 | 1105 | 0.160 |
Why?
|
| Churg-Strauss Syndrome | 1 | 1999 | 70 | 0.160 |
Why?
|
| Systole | 1 | 2001 | 958 | 0.160 |
Why?
|
| Fourier Analysis | 4 | 2004 | 447 | 0.160 |
Why?
|
| Diastole | 1 | 2001 | 791 | 0.160 |
Why?
|
| Motion | 4 | 2016 | 798 | 0.160 |
Why?
|
| Airway Obstruction | 6 | 2010 | 664 | 0.160 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.160 |
Why?
|
| Antibodies, Monoclonal | 6 | 2017 | 9274 | 0.160 |
Why?
|
| Patient Selection | 2 | 2020 | 4216 | 0.160 |
Why?
|
| Matrix Metalloproteinase 7 | 2 | 2015 | 58 | 0.160 |
Why?
|
| Heart Failure | 1 | 2022 | 10895 | 0.160 |
Why?
|
| Models, Animal | 4 | 2007 | 2173 | 0.150 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2022 | 388 | 0.150 |
Why?
|
| Immunotherapy | 6 | 2022 | 4446 | 0.150 |
Why?
|
| Asbestosis | 1 | 2017 | 82 | 0.150 |
Why?
|
| Internship and Residency | 4 | 2007 | 5791 | 0.150 |
Why?
|
| Boston | 2 | 2021 | 9312 | 0.150 |
Why?
|
| Exercise Tolerance | 3 | 2012 | 768 | 0.150 |
Why?
|
| Predictive Value of Tests | 11 | 2022 | 15078 | 0.150 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2012 | 382 | 0.150 |
Why?
|
| Iohexol | 3 | 2014 | 196 | 0.150 |
Why?
|
| Immunocompromised Host | 2 | 2019 | 847 | 0.150 |
Why?
|
| Prognosis | 13 | 2020 | 29060 | 0.150 |
Why?
|
| Risk Factors | 14 | 2023 | 72296 | 0.150 |
Why?
|
| Risk Adjustment | 1 | 2021 | 594 | 0.140 |
Why?
|
| Goiter | 4 | 1993 | 87 | 0.140 |
Why?
|
| Longitudinal Studies | 8 | 2021 | 13991 | 0.140 |
Why?
|
| Respiratory Physiological Phenomena | 2 | 2007 | 188 | 0.140 |
Why?
|
| Coronary Angiography | 2 | 2006 | 4576 | 0.140 |
Why?
|
| Thyroid Neoplasms | 8 | 1993 | 2282 | 0.140 |
Why?
|
| Antirheumatic Agents | 2 | 2023 | 1338 | 0.140 |
Why?
|
| Leukemia, Myeloid | 1 | 2019 | 707 | 0.140 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 3666 | 0.140 |
Why?
|
| Regional Blood Flow | 6 | 2007 | 1525 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5867 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1184 | 0.140 |
Why?
|
| Calcinosis | 2 | 2003 | 1499 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2020 | 6539 | 0.130 |
Why?
|
| Swine | 9 | 2003 | 5918 | 0.130 |
Why?
|
| Radiopharmaceuticals | 5 | 2014 | 2645 | 0.130 |
Why?
|
| Lung Transplantation | 2 | 2023 | 1155 | 0.130 |
Why?
|
| Body Weight | 1 | 2006 | 4671 | 0.130 |
Why?
|
| Self Report | 2 | 2018 | 3553 | 0.130 |
Why?
|
| Risk Assessment | 7 | 2020 | 23336 | 0.130 |
Why?
|
| Opportunistic Infections | 1 | 2018 | 389 | 0.130 |
Why?
|
| Galectin 3 | 1 | 2016 | 227 | 0.120 |
Why?
|
| Mediastinal Cyst | 1 | 2014 | 29 | 0.120 |
Why?
|
| Carcinoma, Bronchogenic | 2 | 2007 | 87 | 0.120 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 1062 | 0.120 |
Why?
|
| Pseudolymphoma | 1 | 2014 | 30 | 0.120 |
Why?
|
| Lung Volume Measurements | 2 | 2006 | 378 | 0.120 |
Why?
|
| Lung Injury | 1 | 2019 | 436 | 0.120 |
Why?
|
| Neoplasms | 8 | 2021 | 21696 | 0.120 |
Why?
|
| Prospective Studies | 21 | 2023 | 53290 | 0.120 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2018 | 2016 | 0.120 |
Why?
|
| Vital Capacity | 4 | 2019 | 925 | 0.120 |
Why?
|
| Young Adult | 11 | 2020 | 56429 | 0.120 |
Why?
|
| Chemokine CXCL10 | 1 | 2015 | 305 | 0.120 |
Why?
|
| Pulmonary Diffusing Capacity | 4 | 2011 | 88 | 0.120 |
Why?
|
| Trachea | 3 | 2011 | 1076 | 0.110 |
Why?
|
| Follow-Up Studies | 13 | 2023 | 39052 | 0.110 |
Why?
|
| DNA | 2 | 2018 | 7294 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2004 | 1431 | 0.110 |
Why?
|
| Linear Models | 6 | 2019 | 5953 | 0.110 |
Why?
|
| Vehicle Emissions | 1 | 2018 | 665 | 0.110 |
Why?
|
| Survival Rate | 7 | 2021 | 12788 | 0.110 |
Why?
|
| Autoantibodies | 5 | 2015 | 2036 | 0.110 |
Why?
|
| Carcinoma, Papillary | 4 | 1993 | 783 | 0.110 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 551 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 17446 | 0.110 |
Why?
|
| Regression Analysis | 5 | 2016 | 6459 | 0.110 |
Why?
|
| Respiratory Tract Diseases | 1 | 2018 | 722 | 0.110 |
Why?
|
| Thoracic Surgical Procedures | 2 | 2009 | 342 | 0.110 |
Why?
|
| Cystic Fibrosis | 2 | 2019 | 1178 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 484 | 0.100 |
Why?
|
| Carbon Monoxide | 1 | 2015 | 531 | 0.100 |
Why?
|
| Subtraction Technique | 3 | 2012 | 525 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 1179 | 0.100 |
Why?
|
| Thyroiditis | 2 | 1993 | 85 | 0.100 |
Why?
|
| Animals | 27 | 2018 | 168768 | 0.100 |
Why?
|
| Thyroiditis, Suppurative | 1 | 1990 | 8 | 0.100 |
Why?
|
| Pituitary Gland | 2 | 2007 | 665 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2019 | 880 | 0.100 |
Why?
|
| Stroke Volume | 2 | 2022 | 5006 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2019 | 15520 | 0.090 |
Why?
|
| Liver Neoplasms | 7 | 2016 | 4253 | 0.090 |
Why?
|
| ROC Curve | 8 | 2017 | 3528 | 0.090 |
Why?
|
| Physical Examination | 1 | 2016 | 1237 | 0.090 |
Why?
|
| Japan | 4 | 2019 | 1360 | 0.090 |
Why?
|
| Receptors, Thyrotropin | 4 | 1994 | 45 | 0.090 |
Why?
|
| Pneumothorax | 3 | 2004 | 379 | 0.090 |
Why?
|
| Time Factors | 11 | 2021 | 40075 | 0.090 |
Why?
|
| Mutation | 8 | 2021 | 29786 | 0.090 |
Why?
|
| Radionuclide Imaging | 9 | 2004 | 2031 | 0.090 |
Why?
|
| Aortic Diseases | 2 | 2010 | 743 | 0.090 |
Why?
|
| Radiology Department, Hospital | 2 | 2004 | 412 | 0.090 |
Why?
|
| Densitometry | 1 | 2010 | 156 | 0.090 |
Why?
|
| Ultrasonography | 9 | 2002 | 5984 | 0.090 |
Why?
|
| Hypothyroidism | 4 | 1999 | 658 | 0.090 |
Why?
|
| Comorbidity | 3 | 2009 | 10388 | 0.090 |
Why?
|
| Aging | 2 | 2021 | 8664 | 0.090 |
Why?
|
| Thyroid Diseases | 4 | 2002 | 379 | 0.090 |
Why?
|
| Pharyngeal Diseases | 1 | 1990 | 133 | 0.090 |
Why?
|
| Residual Volume | 2 | 2011 | 41 | 0.090 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2016 | 3143 | 0.090 |
Why?
|
| Logistic Models | 7 | 2019 | 13409 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2023 | 12262 | 0.080 |
Why?
|
| Family | 1 | 2020 | 3147 | 0.080 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2009 | 107 | 0.080 |
Why?
|
| Gadolinium | 3 | 2003 | 952 | 0.080 |
Why?
|
| Adolescent | 21 | 2020 | 85779 | 0.080 |
Why?
|
| Computer Graphics | 1 | 2011 | 361 | 0.080 |
Why?
|
| Perfusion | 4 | 2007 | 1360 | 0.080 |
Why?
|
| Age Distribution | 2 | 2006 | 2902 | 0.080 |
Why?
|
| Immunoglobulin G | 7 | 1991 | 4561 | 0.080 |
Why?
|
| Fistula | 1 | 1990 | 220 | 0.080 |
Why?
|
| Carbon Isotopes | 1 | 2009 | 467 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2003 | 6077 | 0.080 |
Why?
|
| Biopsy, Needle | 2 | 2004 | 1641 | 0.080 |
Why?
|
| Treatment Outcome | 15 | 2023 | 63107 | 0.080 |
Why?
|
| Gene Expression | 3 | 2023 | 7798 | 0.080 |
Why?
|
| Institutional Management Teams | 1 | 2007 | 31 | 0.080 |
Why?
|
| Iodine | 1 | 2010 | 286 | 0.080 |
Why?
|
| Triage | 1 | 2015 | 977 | 0.080 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2009 | 101 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 964 | 0.080 |
Why?
|
| Sirolimus | 1 | 2015 | 1565 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2021 | 3444 | 0.080 |
Why?
|
| Melanoma | 3 | 2016 | 5511 | 0.080 |
Why?
|
| Lymph Nodes | 4 | 2004 | 3476 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 506 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2020 | 9240 | 0.080 |
Why?
|
| Adenocarcinoma | 5 | 2012 | 6364 | 0.080 |
Why?
|
| Collagen Type I | 1 | 2010 | 592 | 0.070 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 9 | 1994 | 34 | 0.070 |
Why?
|
| Body Mass Index | 4 | 2015 | 12721 | 0.070 |
Why?
|
| Telomere | 2 | 2024 | 910 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 495 | 0.070 |
Why?
|
| Amyloidosis | 2 | 1991 | 796 | 0.070 |
Why?
|
| Physician Executives | 1 | 2007 | 128 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 2569 | 0.070 |
Why?
|
| Fetal Organ Maturity | 1 | 2006 | 82 | 0.070 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2010 | 450 | 0.070 |
Why?
|
| Particulate Matter | 1 | 2018 | 2529 | 0.070 |
Why?
|
| Obesity | 2 | 2019 | 12746 | 0.070 |
Why?
|
| Pyrazoles | 1 | 2016 | 1972 | 0.070 |
Why?
|
| Acute Disease | 5 | 2018 | 7147 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 1541 | 0.070 |
Why?
|
| Equipment Failure Analysis | 1 | 2009 | 868 | 0.070 |
Why?
|
| Continuity of Patient Care | 1 | 2013 | 1049 | 0.070 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2015 | 1052 | 0.070 |
Why?
|
| Rodentia | 1 | 2007 | 261 | 0.070 |
Why?
|
| Paragonimiasis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Arteriosclerosis | 1 | 2010 | 1092 | 0.070 |
Why?
|
| Lung Diseases, Parasitic | 1 | 2005 | 14 | 0.070 |
Why?
|
| Thyroiditis, Autoimmune | 5 | 1994 | 101 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2021 | 3749 | 0.070 |
Why?
|
| Triiodobenzoic Acids | 1 | 2005 | 124 | 0.070 |
Why?
|
| Thyrotropin | 7 | 1991 | 849 | 0.070 |
Why?
|
| Thoracic Wall | 1 | 2007 | 203 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2010 | 971 | 0.060 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 56 | 0.060 |
Why?
|
| Cause of Death | 1 | 2016 | 3582 | 0.060 |
Why?
|
| Filtration | 1 | 2006 | 234 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2012 | 2038 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2010 | 20824 | 0.060 |
Why?
|
| Mass Screening | 1 | 2021 | 5253 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2010 | 973 | 0.060 |
Why?
|
| Computer Simulation | 3 | 2012 | 6194 | 0.060 |
Why?
|
| Mediastinum | 2 | 2004 | 267 | 0.060 |
Why?
|
| Pyridines | 1 | 2016 | 2825 | 0.060 |
Why?
|
| Models, Educational | 1 | 2007 | 377 | 0.060 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 15160 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2011 | 2618 | 0.060 |
Why?
|
| Chronic Disease | 6 | 2019 | 9145 | 0.060 |
Why?
|
| Sodium Pertechnetate Tc 99m | 2 | 2002 | 57 | 0.060 |
Why?
|
| Spin Labels | 2 | 2003 | 332 | 0.060 |
Why?
|
| Fetus | 2 | 2006 | 1880 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2015 | 2585 | 0.060 |
Why?
|
| Registries | 3 | 2019 | 8091 | 0.060 |
Why?
|
| Disease-Free Survival | 4 | 2017 | 6896 | 0.060 |
Why?
|
| Radionuclide Angiography | 1 | 2004 | 23 | 0.060 |
Why?
|
| Air Pollution | 1 | 2018 | 2286 | 0.060 |
Why?
|
| Health Status | 1 | 2018 | 4034 | 0.060 |
Why?
|
| Venules | 1 | 2004 | 165 | 0.060 |
Why?
|
| Sex Factors | 2 | 2015 | 10400 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2011 | 1431 | 0.060 |
Why?
|
| Arteriovenous Malformations | 2 | 2002 | 396 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 2 | 2012 | 2727 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 3 | 2009 | 3616 | 0.060 |
Why?
|
| Mediastinal Neoplasms | 2 | 2001 | 423 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 2073 | 0.060 |
Why?
|
| Cartilage Diseases | 1 | 2005 | 160 | 0.060 |
Why?
|
| Echo-Planar Imaging | 2 | 1999 | 659 | 0.060 |
Why?
|
| Hospitalization | 1 | 2023 | 10259 | 0.060 |
Why?
|
| Equipment Safety | 1 | 2004 | 263 | 0.060 |
Why?
|
| Organometallic Compounds | 2 | 1997 | 665 | 0.060 |
Why?
|
| Kinetics | 1 | 2011 | 6476 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 3508 | 0.060 |
Why?
|
| Intubation | 1 | 2003 | 141 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 12244 | 0.050 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 1420 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2012 | 4034 | 0.050 |
Why?
|
| Case-Control Studies | 5 | 2020 | 21748 | 0.050 |
Why?
|
| Systems Integration | 1 | 2004 | 440 | 0.050 |
Why?
|
| Safety | 2 | 2007 | 1186 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2004 | 520 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2004 | 298 | 0.050 |
Why?
|
| Abdomen | 2 | 2011 | 1118 | 0.050 |
Why?
|
| Remission Induction | 2 | 2019 | 2385 | 0.050 |
Why?
|
| Reference Values | 6 | 2003 | 4982 | 0.050 |
Why?
|
| Iodine Radioisotopes | 4 | 1994 | 1032 | 0.050 |
Why?
|
| Odds Ratio | 3 | 2021 | 9849 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3799 | 0.050 |
Why?
|
| Massachusetts | 2 | 2017 | 8662 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4772 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 1011 | 0.050 |
Why?
|
| Phlebography | 1 | 2002 | 333 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2010 | 7282 | 0.050 |
Why?
|
| Magnetics | 2 | 2003 | 606 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2016 | 18034 | 0.050 |
Why?
|
| Software | 2 | 2012 | 4441 | 0.050 |
Why?
|
| TATA Box Binding Protein-Like Proteins | 1 | 2019 | 8 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2006 | 824 | 0.050 |
Why?
|
| Iodized Oil | 2 | 1992 | 10 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2016 | 25039 | 0.040 |
Why?
|
| Pericardium | 1 | 2004 | 667 | 0.040 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2021 | 176 | 0.040 |
Why?
|
| beta Karyopherins | 1 | 2019 | 47 | 0.040 |
Why?
|
| Blood Volume | 1 | 2001 | 565 | 0.040 |
Why?
|
| Radiography, Interventional | 2 | 2004 | 1095 | 0.040 |
Why?
|
| Leukemic Infiltration | 1 | 2019 | 48 | 0.040 |
Why?
|
| United States | 7 | 2017 | 69872 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 1 | 2008 | 1020 | 0.040 |
Why?
|
| Cyclic AMP | 5 | 1990 | 1472 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11525 | 0.040 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 175 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 1144 | 0.040 |
Why?
|
| Clinical Trials as Topic | 4 | 2017 | 7914 | 0.040 |
Why?
|
| Proteomics | 2 | 2022 | 3638 | 0.040 |
Why?
|
| Recurrence | 4 | 2012 | 8340 | 0.040 |
Why?
|
| Organ Size | 2 | 2016 | 2251 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2013 | 5101 | 0.040 |
Why?
|
| Cadaver | 1 | 2002 | 1337 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1991 | 4554 | 0.040 |
Why?
|
| Models, Biological | 2 | 2012 | 9584 | 0.040 |
Why?
|
| Adipose Tissue | 3 | 2019 | 3280 | 0.040 |
Why?
|
| Biopsy | 1 | 2010 | 6755 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2012 | 5023 | 0.040 |
Why?
|
| Prostatic Hyperplasia | 1 | 2002 | 523 | 0.040 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6486 | 0.040 |
Why?
|
| Hyperthyroidism | 3 | 1989 | 295 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2003 | 2297 | 0.040 |
Why?
|
| Genomics | 1 | 2014 | 5717 | 0.040 |
Why?
|
| Arteries | 2 | 2001 | 1119 | 0.040 |
Why?
|
| Body Water | 1 | 1999 | 343 | 0.040 |
Why?
|
| Microscopy | 1 | 2003 | 902 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3873 | 0.040 |
Why?
|
| Meglumine | 2 | 1996 | 149 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1461 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2009 | 6366 | 0.040 |
Why?
|
| Genotype | 3 | 2018 | 12952 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10483 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2011 | 4851 | 0.040 |
Why?
|
| Decision Trees | 1 | 2019 | 506 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 2638 | 0.040 |
Why?
|
| Cineangiography | 1 | 1996 | 124 | 0.040 |
Why?
|
| Microspheres | 1 | 1999 | 777 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2012 | 3481 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3255 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 1985 | 2765 | 0.040 |
Why?
|
| Electrocardiography | 3 | 2001 | 6442 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 610 | 0.040 |
Why?
|
| Pentetic Acid | 1 | 1996 | 213 | 0.040 |
Why?
|
| Heterocyclic Compounds | 1 | 1997 | 249 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2019 | 8861 | 0.030 |
Why?
|
| Pleural Effusion | 1 | 2019 | 337 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 1990 | 2214 | 0.030 |
Why?
|
| Denmark | 1 | 2018 | 738 | 0.030 |
Why?
|
| Fibroma | 1 | 1997 | 212 | 0.030 |
Why?
|
| Airway Remodeling | 1 | 2016 | 132 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 49 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 1989 | 881 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 4262 | 0.030 |
Why?
|
| Gallium Radioisotopes | 2 | 1992 | 178 | 0.030 |
Why?
|
| Prednisolone | 1 | 2016 | 334 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1275 | 0.030 |
Why?
|
| Triiodothyronine | 4 | 1989 | 494 | 0.030 |
Why?
|
| Prostate | 1 | 2002 | 1775 | 0.030 |
Why?
|
| Palliative Care | 1 | 2009 | 3493 | 0.030 |
Why?
|
| Walking | 2 | 2012 | 1180 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2020 | 23404 | 0.030 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 319 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 11718 | 0.030 |
Why?
|
| Stents | 1 | 2005 | 3282 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1999 | 1125 | 0.030 |
Why?
|
| Pedigree | 1 | 2021 | 4642 | 0.030 |
Why?
|
| Methotrexate | 1 | 2019 | 1728 | 0.030 |
Why?
|
| Thymoma | 1 | 2014 | 186 | 0.030 |
Why?
|
| Citrates | 1 | 1992 | 131 | 0.030 |
Why?
|
| Technology, Radiologic | 2 | 2007 | 163 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2018 | 956 | 0.030 |
Why?
|
| Palate, Soft | 1 | 1992 | 96 | 0.030 |
Why?
|
| Monocytes | 1 | 2022 | 2596 | 0.030 |
Why?
|
| Software Validation | 1 | 2012 | 59 | 0.030 |
Why?
|
| Succimer | 1 | 1991 | 31 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 4 | 2000 | 1681 | 0.030 |
Why?
|
| Organotechnetium Compounds | 1 | 1991 | 137 | 0.030 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 1991 | 84 | 0.020 |
Why?
|
| Thyroglobulin | 1 | 1991 | 114 | 0.020 |
Why?
|
| Drug Combinations | 1 | 1996 | 1958 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 224 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 5709 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2007 | 8551 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2015 | 1655 | 0.020 |
Why?
|
| Antibodies | 2 | 1990 | 2460 | 0.020 |
Why?
|
| Chemokines | 1 | 2015 | 970 | 0.020 |
Why?
|
| Bronchioles | 1 | 2010 | 25 | 0.020 |
Why?
|
| Bleomycin | 1 | 2012 | 512 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1995 | 950 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 2110 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 940 | 0.020 |
Why?
|
| Spleen | 1 | 1997 | 2362 | 0.020 |
Why?
|
| Thyroiditis, Subacute | 1 | 1990 | 10 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2011 | 280 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2575 | 0.020 |
Why?
|
| Lasers | 2 | 2007 | 952 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2019 | 2108 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 2861 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2916 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2010 | 436 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 1581 | 0.020 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1990 | 188 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3279 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1660 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2013 | 599 | 0.020 |
Why?
|
| Life Style | 1 | 2020 | 3835 | 0.020 |
Why?
|
| Iodides | 1 | 1988 | 41 | 0.020 |
Why?
|
| Fibrinolysis | 1 | 1990 | 322 | 0.020 |
Why?
|
| China | 1 | 2015 | 2245 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2009 | 264 | 0.020 |
Why?
|
| Quality of Life | 2 | 2022 | 12802 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1991 | 575 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 2419 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 3464 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5172 | 0.020 |
Why?
|
| Rubidium | 1 | 2007 | 133 | 0.020 |
Why?
|
| Thyroxine | 2 | 1989 | 667 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1996 | 1253 | 0.020 |
Why?
|
| Adenoma, Bile Duct | 1 | 1987 | 30 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 919 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 1856 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2007 | 254 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2012 | 1794 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2011 | 537 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 980 | 0.020 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2007 | 67 | 0.020 |
Why?
|
| Myocardial Contraction | 2 | 1990 | 1579 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1988 | 224 | 0.020 |
Why?
|
| Cleft Palate | 1 | 1992 | 560 | 0.020 |
Why?
|
| Bronchiolitis Obliterans | 1 | 1988 | 194 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5388 | 0.020 |
Why?
|
| Embolization, Therapeutic | 2 | 2002 | 1392 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 1868 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4925 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 2455 | 0.020 |
Why?
|
| Temperature | 2 | 2009 | 2204 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 2120 | 0.020 |
Why?
|
| Lymphography | 1 | 1987 | 201 | 0.020 |
Why?
|
| Paragonimus westermani | 1 | 2005 | 2 | 0.020 |
Why?
|
| Liver | 2 | 2019 | 7475 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 2 | 2011 | 2716 | 0.020 |
Why?
|
| Bone Density | 1 | 2019 | 3468 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6933 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2556 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1991 | 988 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2017 | 3461 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1992 | 2234 | 0.020 |
Why?
|
| Pregnancy | 6 | 2006 | 29144 | 0.020 |
Why?
|
| Hematuria | 1 | 1986 | 235 | 0.020 |
Why?
|
| Cell Division | 1 | 1992 | 4569 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2007 | 597 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2005 | 15297 | 0.020 |
Why?
|
| Mice | 4 | 2016 | 81201 | 0.020 |
Why?
|
| Cell Line | 4 | 1992 | 16000 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11366 | 0.020 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 2004 | 85 | 0.020 |
Why?
|
| Exercise Test | 1 | 2012 | 2073 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2971 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2566 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1990 | 1127 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4185 | 0.010 |
Why?
|
| Injections | 1 | 2007 | 840 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.010 |
Why?
|
| Gestational Age | 2 | 2006 | 3493 | 0.010 |
Why?
|
| Thrombosis | 1 | 2017 | 2968 | 0.010 |
Why?
|
| Heart | 1 | 1997 | 4464 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1985 | 201 | 0.010 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1986 | 504 | 0.010 |
Why?
|
| Vasodilation | 1 | 2007 | 944 | 0.010 |
Why?
|
| Ureter | 1 | 1986 | 375 | 0.010 |
Why?
|
| Outpatients | 1 | 2011 | 1487 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 1150 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1986 | 440 | 0.010 |
Why?
|
| Oxygen Radioisotopes | 1 | 2002 | 76 | 0.010 |
Why?
|
| Chest Tubes | 1 | 2003 | 150 | 0.010 |
Why?
|
| Dyspnea | 1 | 2010 | 1303 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 1987 | 567 | 0.010 |
Why?
|
| Adenoma | 1 | 1992 | 2174 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 1107 | 0.010 |
Why?
|
| Bone Neoplasms | 2 | 1991 | 2530 | 0.010 |
Why?
|
| Exercise | 1 | 2018 | 5615 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3480 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1995 | 2736 | 0.010 |
Why?
|
| Bone Marrow | 2 | 1997 | 2948 | 0.010 |
Why?
|
| Balloon Occlusion | 1 | 2001 | 126 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1997 | 4839 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2004 | 924 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1985 | 1402 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1671 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8319 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2002 | 11126 | 0.010 |
Why?
|
| Gravitation | 1 | 1999 | 82 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1985 | 2726 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 3759 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6386 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1842 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2002 | 1590 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 1423 | 0.010 |
Why?
|
| Rabbits | 1 | 1985 | 4894 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 5263 | 0.010 |
Why?
|
| Heart Rate | 1 | 1989 | 4092 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7182 | 0.010 |
Why?
|
| Rats | 2 | 1991 | 24252 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2012 | 4600 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1985 | 2216 | 0.010 |
Why?
|
| Thyroidectomy | 2 | 1993 | 879 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1999 | 1185 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2003 | 2453 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1991 | 13035 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9735 | 0.010 |
Why?
|
| Thrombophlebitis | 1 | 1995 | 309 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1991 | 4583 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 21833 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1991 | 9647 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1991 | 5181 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1986 | 1968 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1157 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8642 | 0.010 |
Why?
|
| Ovary | 1 | 1997 | 981 | 0.010 |
Why?
|
| Citric Acid | 1 | 1992 | 126 | 0.010 |
Why?
|
| Palate | 1 | 1992 | 123 | 0.010 |
Why?
|
| Ploidies | 1 | 1992 | 281 | 0.010 |
Why?
|
| Leiomyoma | 1 | 1997 | 730 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1992 | 234 | 0.010 |
Why?
|
| Thallium Radioisotopes | 1 | 1991 | 139 | 0.010 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 1991 | 79 | 0.010 |
Why?
|
| Velopharyngeal Insufficiency | 1 | 1992 | 87 | 0.010 |
Why?
|
| Phonetics | 1 | 1992 | 206 | 0.010 |
Why?
|
| Phonation | 1 | 1992 | 219 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1992 | 245 | 0.010 |
Why?
|
| Pharynx | 1 | 1992 | 413 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 1994 | 460 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 1990 | 332 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 1990 | 19233 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1990 | 263 | 0.010 |
Why?
|
| Bucladesine | 1 | 1988 | 121 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1988 | 147 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1988 | 374 | 0.010 |
Why?
|
| Uterine Neoplasms | 1 | 1997 | 1513 | 0.000 |
Why?
|
| Antithyroid Agents | 1 | 1988 | 70 | 0.000 |
Why?
|
| Technetium | 1 | 1988 | 334 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1996 | 1161 | 0.000 |
Why?
|
| Chorionic Gonadotropin | 1 | 1989 | 476 | 0.000 |
Why?
|
| Culture Media | 1 | 1989 | 909 | 0.000 |
Why?
|
| Platelet Count | 1 | 1990 | 780 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1989 | 625 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1990 | 894 | 0.000 |
Why?
|
| Renal Veins | 1 | 1986 | 108 | 0.000 |
Why?
|
| Biological Assay | 1 | 1988 | 652 | 0.000 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1992 | 990 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1992 | 4933 | 0.000 |
Why?
|
| Asthma | 1 | 2001 | 6010 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1992 | 2943 | 0.000 |
Why?
|
| Societies, Medical | 1 | 1994 | 3743 | 0.000 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1990 | 1421 | 0.000 |
Why?
|
| Child | 2 | 2002 | 77709 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1988 | 10943 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1992 | 11486 | 0.000 |
Why?
|